Orchid Pharma Limited

Overview

Orchid Pharma Limited is an Indian pharmaceutical company that specializes in the development and manufacturing of diverse pharmaceutical products. A leader in the production of cephalosporin antibiotics, Orchid Pharma operates in both domestic and international markets.

Therapeutic areas

API / Drug Master Files

Orchid Pharma Limited holds 45 active (45 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CEFTAZIDIME + AVIBACTAM (STERILE)Active2024-01-25
• AVIBACTAM SODIUM STERILEActive2024-01-23
• ALMOTRIPTAN MALATEActive2012-07-13
• CEFEPIME HCI USPActive2011-11-28
• DEXLANSOPRAZOLEActive2011-08-31
• CLOPIDOGREL BISULFATEActive2011-08-26
• ARMODAFINILActive2011-06-23
• RABEPRAZOLE SODIUMActive2011-06-18
• PALIPERIDONEActive2011-02-03
• CEFUROXIME AXETIL (CRYSTALLINE) (NON-STERILE BULK API)Active2010-06-29
• TOLTERODINE TARTRATE (NON-STERILE BULK API)Active2010-03-31
• CEFTAZIDIME + SODIUM CARBONATE (STERILE BULK)Active2009-12-29
• SODIUM CARBONATE (STERILE)Active2009-12-28
• CEFTAZIDIME (STERILE)Active2009-12-24
• TRANS-RESVERATROL (SERIES A)Active2009-03-31

Showing 15 of 45 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Orchid Pharma Limited in our records. PharmaTek screens the full directory against live FDA enforcement data.